What is the intrinsic value of CYRX?
As of 2025-09-16, the Intrinsic Value of Cryoport Inc (CYRX) is
7.52 USD. This CYRX valuation is based on the model Peter Lynch Fair Value.
With the current market price of 8.77 USD, the upside of Cryoport Inc is
-14.23%.
Is CYRX undervalued or overvalued?
Based on its market price of 8.77 USD and our intrinsic valuation, Cryoport Inc (CYRX) is overvalued by 14.23%.
CYRX Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
(175.94) - (23.95) |
(41.67) |
-575.1% |
| DCF (Growth 10y) |
(23.63) - (155.08) |
(39.15) |
-546.4% |
| DCF (EBITDA 5y) |
(12.61) - (19.90) |
(1,234.50) |
-123450.0% |
| DCF (EBITDA 10y) |
(15.46) - (23.83) |
(1,234.50) |
-123450.0% |
| Fair Value |
7.52 - 7.52 |
7.52 |
-14.23% |
| P/E |
27.83 - 62.46 |
46.00 |
424.5% |
| EV/EBITDA |
(9.20) - (7.53) |
(7.59) |
-186.5% |
| EPV |
(10.84) - (18.39) |
(14.61) |
-266.6% |
| DDM - Stable |
13.52 - 77.76 |
45.64 |
420.4% |
| DDM - Multi |
(14.03) - (65.15) |
(23.35) |
-366.3% |
CYRX Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
439.11 |
| Beta |
0.97 |
| Outstanding shares (mil) |
50.07 |
| Enterprise Value (mil) |
382.89 |
| Market risk premium |
4.60% |
| Cost of Equity |
8.76% |
| Cost of Debt |
5.50% |
| WACC |
7.72% |